Recent posts and comments

• Alnylam, Aveo, Biogen, & More Boston Life Sciences Newsmakers

  Clinical trial results and drug collaborators made up the New England life sciences news this week.

  —New Jersey-based drugmaker Merck announced backing a few Boston-area companies in the past few weeks. Its Global... Read more »

• FirstFuel Software Selected for DoD Energy Efficiency Initiative

  Lexington, MA-based FirstFuel Software is among a crop of experimental energy projects picked to help the Department of Defense curb its energy output across military installations, the company announced yesterday. The... Read more »

• Report: Sermo Founders Off to New Company

  Founders of Sermo, the Cambridge, MA-based provider of an online community for physicians, are off to a new health-focused Web startup. The news was first reported today at online publication Pharmalot, which noted... Read more »

• Xconomy is Looking for a Digital Media Intern to Join Our Cambridge Offices

  Hey intern hopefuls, have you been on the hunt for a sweet media gig for the new semester? You’re in luck. Xconomy is looking for a rockstar intern to help out with a mix... Read more »

• Smart Destinations Out to Make Big City Tourist Travel Family-Friendly

  Boston has a pretty well-known cluster of tech companies—young and old—that are focused on aspects of travel like booking flights and hotels. Kayak, TripAdvisor, and ITA Software (now part of Google),... Read more »

• Momenta, Baxter Team Up on Biosimilars

  Illinois-based Baxter International (NYSE: BAX) is tapping into Cambridge, MA-based Momenta Pharmaceuticals’ abilities as a generic drugmaker in a new collaboration deal focused on developing so-called biosimilars, or knockoffs of biologic drugs.

  Momenta (NASDAQ: MNTA... Read more »

• Millennium, Metamark, Amgen, & More Boston Life Sciences Headlines

  Big drug collaborations and acquisitions took the spotlight in the New England life sciences news pool this week.

  —Coronado Biosciences, which moved from New York to Burlington, MA, this past August, debuted on... Read more »

• PatientKeeper Inks $6M, Promotes Hazard to Chairman

  Waltham, MA-based health IT company PatientKeeper announced today that it has added $6 million in growth financing, from Flybridge Capital Partners, New Enterprise Associates and Whitney & Company.

  The company, which makes... Read more »

• Boston-Power Adds $30M to Bring Venture Funding Pot to $346M

  Anyone who says cleantech companies are having a tough time raising money should take a look at Boston-Power. The Westborough, MA-based advanced lithium-ion battery maker is announcing today that it’s taken in $30... Read more »

• IBM Gets Emptoris, Nuance Buys Vlingo, & More Boston-Area Deals News

  Acquisitions and IPO announcements dominated the deals news in New England this week.

  —Boston-based Third Rock Ventures put $34 million in Series A funding into Ember Therapeutics, a startup that’s developing drugs to... Read more »

• Nuance’s Vlingo Purchase Seen As Survival Move Against Apple, Google

  It’s hard to believe that two companies that have spent the last three years suing each other really mean it when they say that together they will be stronger. I’m talking... Read more »

• After Years of Legal Battles, Vlingo to Be Acquired by Nuance

  Cambridge, MA-based voice-to-text tech startup Vlingo, which just three months ago charged Nuance Communications with unfair competition, commercial bribery, breach of contract, and intentional interference with prospective business relationships, is... Read more »

• Vertex, Ariad, Alnylam, & More Boston-Area Life Sciences Newsmakers

  New England saw a flurry of life sciences news this week, from venture firms, new startups, and established biotechs.

  —Boston-based Avila Therapeutics presented data at the American Society of Hematology from early... Read more »

• Swipely Expands Card-Linked Customer Loyalty Program to Boston

  Providence, RI-based Swipely is kicking off a discount program in Boston that it says will give shoppers discounts and earn local merchants a more loyal, consistent customer base.

  Swipely first got started as a platform... Read more »

• Kinvey, Zink, ImmusanT, and More of this Week’s Boston Dealmakers

  IT and life sciences companies around New England shared the deals news pool this week.

  —Zink pinned down $35 million in a Series B round led by Genii Capital. The Bedford, MA-based... Read more »

• ImmusanT, Developing Celiac Disease Treatments, Closes $20M Series A

  Cambridge, MA-based ImmusanT, a new biotech working on therapies targeting celiac disease, announced today that it has wrapped up $20 million in Series A financing from New York-based Vatera Healthcare Partners.

  The money... Read more »

• Fiksu Releases Service to Make Paid Mobile Apps Free for Consumers

  Boston-based Fiksu, a startup focused on mobile app marketing, is introducing a new service today that it says will get consumers paid mobile apps for free, while still bringing mobile app developers... Read more »

• LifeImage Wraps Up $8M in New Funding

  [Updated 12/9/11 at 11:45 am. See below.] LifeImage, a Newton, MA-based startup that develops technology for sharing digital medical images via the Internet cloud, has taken in $8 million... Read more »

• EnVivo, Biogen, Momenta, & Other Boston-Area Life Sciences Newsmakers

  Drugs, conglomerates, medical nutrition companies, and biotechs dominated the New England life sciences news this week.

  —EnVivo Pharmaceuticals of Watertown, MA, said its experimental schizophrenia drug EVP-6124 demonstrated statistically significant improvements... Read more »

• Cambrooke Foods Aims to Help Nourish Patients with Metabolic Disorders

  Ayer, MA-based Cambrooke Foods might be a bit deceiving on the surface. It is not a maker of packaged foods the average shopper would pick up at the grocery store. And its founders... Read more »